Post-Hoc Analysis Of Long-Term Outcomes In Patients With Cr, Pr, Or Sd To Pembrolizumab (Pembro) Or Platinum-Based Chemotherapy (Chemo) As 1l Therapy For Advanced Urothelial Carcinoma (Uc) In Keynote-361.
JOURNAL OF CLINICAL ONCOLOGY（2021）
摘要
435Background: The phase III KEYNOTE-361 study compared efficacy and safety of 1L pembro + chemo or pembro vs chemo in pts with advanced UC. The trial did not meet its primary endpoints of PFS or O...
更多查看译文
关键词
advanced urothelial carcinoma,pembrolizumab,1l chemotherapy,post-hoc,long-term,platinum-based
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要